LIP
DNTH icon

Lighthouse Investment Partners’s Dianthus Therapeutics DNTH Stock Holding History

Lighthouse Investment Partners’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,000
Closed -$824K – 798
2025
Q4 		$824K Buy
+20,000
New +$775K 0.02% 520

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lighthouse Investment Partners's DNTH Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Dianthus Therapeutics (DNTH) in Q1 2026, closing a stake of 20,000 shares — an estimated $824K sold.

Lighthouse Investment Partners first reported a position in DNTH in Q4 2025 and held it in 1 quarter. The position peaked at $824K in Q4 2025. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Dianthus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 20,000 Dianthus Therapeutics shares in Q1 2026, an estimated $824K.
  • Lighthouse Investment Partners first reported a position in Dianthus Therapeutics in Q4 2025 and held it in 1 quarter.
  • Lighthouse Investment Partners's Dianthus Therapeutics position peaked at $824K in Q4 2025.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.